Technology

Two approaches. One tissue source.

LivStem’s initial portfolio includes complementary adipose-tissue processing platforms developed by Genzir Technologies Pvt. Ltd., India, and commercialized in the United States by LivStem Medtech.

GenAdipose

Mechanical adipose-tissue processing

A compact device platform designed for washing and processing lipoaspirate and preparing microfat and nanofat fractions.

Mechanical processing
Lipoaspirate washing
Filtration
Microfat and nanofat preparation

SVF Easy

Enzymatic tissue-to-cell processing

A closed processing device developed to facilitate enzymatic dissociation and isolation of stromal vascular fraction from adipose tissue.

Tissue processing
Enzymatic dissociation workflow
Filtration
Cell fraction collection

Technology origin

Developed by Genzir Technologies. Commercialized in the United States by LivStem Medtech.

GenAdipose and SVF Easy were developed by Genzir Technologies Pvt. Ltd., India. LivStem Medtech is advancing commercialization, collaborations, and market development for these technologies in the United States. SVF Easy is covered by Indian Patent No. 322555.